Abstract

Intermittent Pneumatic Compression (IPC), historically termed Apparative Intermittierende Kompressions therapie (AIK), is a central component of contemporary lymphedema management. This integrative review synthesizes mechanistic, historical, and therapeutic foundations of IPC with findings from a multicenter clin ical evaluation using advanced multi-chamber lymphatic drainage pump systems. Among 448 patients with Stage I-II lower extremity lymphedema treated for three months, 93.08% reported reduced swelling, 86.6% reported decreased pain, and 66.51% experienced combined improvement. These results align with current evidence demonstrating IPC's capacity to enhance lymphatic flow, reduce edema, improve microcirculation, and support venous hemodynamics Barfield et al.and Park et al.. IPC is shown to be clinically beneficial in both decongestive and long-term maintenance phases of lymphedema care.

DOI: doi.org/10.63721/25JCVI0108

To Read or Download the Article  PDF